nikofrenone 21 mg/24 hour patch, 7 pcs

Area of application

The nikofrenon® 21 mg/24 hour patch supports quitting cigarettes and other tobacco products.It helps reduce the withdrawal symptoms of nicotine addiction and makes it easier to quit the addiction.The patch is particularly well tolerated and is gradually reduced over a period of 9 to 12 weeks to reduce physical withdrawal symptoms.

A big advantage of the 24-hour patch over other forms of application is the uniform release of active ingredients.This reduces deficiency symptoms and cravings for nicotine.The continuous availability of the active ingredient over 24 hours also helps to suppress the craving for the first cigarette in the morning.

No prescription is required for this product.

Application

The nikofrenon® 21 mg/24 hour patch is applied once a day in the morning to a healthy, hairless, dry and clean area of skin.Preferred locations are the upper arm, shoulder or upper hip.The patch should be pressed on for 10 to 20 seconds.It is important to change the adhesive areas regularly to avoid skin irritation.After removing the patch, hands should be washed thoroughly to avoid eye irritation.Used plasters should be disposed of carefully and kept out of the reach of children.

The patch is not waterproof, but can be left on the skin with careful showering.However, it should be removed when visiting a sauna or diving to avoid uncontrolled release of nicotine.If the plaster no longer sticks, it can be fixed with a plaster-free plaster.After removal, the patch should be rolled up with the active ingredient side inward and discarded.

Active ingredients / ingredients / ingredients

The nikofrenon® 21 mg/24 hour patch contains the active ingredient nicotine.A transdermal patch contains 52.5 mg of nicotine, with the average release of active ingredient on the skin being 21 mg/24 hours.The other ingredients are acrylate/vinyl acetate/methacrylate copolymer, medium-chain triglycerides, basic butyl methacrylate copolymer (Ph. Eur.), paper, printed carrier film made of poly(ethylene terephthalate), aluminum coated, brown printing ink and protective film made of poly(ethylene terephthalate), aluminum coated and siliconized.

Contraindications

If you are known to be hypersensitive to any of the ingredients, the product should not be used.

Dosage

The duration of use of the nikofrenon® 21 mg/24 hour patch depends on the progress of the treatment.The therapy should last a total of 9 to 12 weeks.The starting dose depends on your previous smoking habits.For optimal treatment, the following dosage regimen should be observed:

Starting phase (3-4 weeks): More than 20 cigarettes per day: nikofrenon® 21 mg/24 hours;up to and including 20 cigarettes per day: nikofrenon® 14 mg/24 hours.

Continuation phase (3-4 weeks): More than 20 cigarettes per day: nikofrenon® 14 mg/24 hours;up to and including 20 cigarettes per day: nikofrenon® 14 mg/24 hours.

Finish (3-4 weeks): More than 20 cigarettes per day: nikofrenon® 7 mg/24 hours;up to and including 20 cigarettes per day: nikofrenon® 7 mg/24 hours.

The dosage should only be reduced after one week of continuous use at the earliest.When you start treatment with nikofrenon® you must stop smoking completely.

Patient information

Please talk to your doctor or pharmacist before using the product if you suffer from stable narrowing of the coronary arteries, older heart attacks, cerebral vascular diseases, circulatory problems in the arms or legs, severely increased blood pressure, heart muscle weakness, kidney and liver problems, hyperthyroidism, epilepsy, muscle weakness, diabetes, inflammation of the gastric mucosa or acute stomach and intestinal ulcers.In these cases you should talk to your doctor before using the medicine.

Children must not be treated with this preparation.There is no experience with its use in patients under 18 years of age.There is only limited experience with its use in smokers over 65 years of age, but the effectiveness and tolerability in this age group appear to be unproblematic.

There is no evidence of risks in road traffic or when operating machines as long as the recommended dosage is adhered to.However, keep in mind that quitting smoking can cause behavioral changes.

Pregnancy

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.Smoking can cause serious harm to the fetus and infant and should be stopped.Pregnant smokers are recommended to quit smoking without the support of medicines containing nicotine.The use of this preparation should only be considered after consulting your doctor if there is a risk of continuing to smoke.

Nicotine passes into breast milk.When using the drug in therapeutic doses, nicotine levels in breast milk can be achieved, which have an effect on the child.If nicotine substitution with the preparation is necessary during breastfeeding, the infant should be switched to formula feeding.

Smoking can have adverse effects on female and male fertility.It is not known what specific contribution nicotine has to these effects.However, if possible, women who want to have children should neither smoke nor take nicotine replacement therapy.

Notes

The transdermal patches must be kept out of the reach of children before and after use.There are no studies available on treatment times totaling more than 3 months and dosages of more than 1 transdermal patch nikofrenon® per day.Any deviation from this should therefore only be made after consulting a doctor.Dosage adjustment cannot be achieved by cutting a transdermal patch.Cutting can lead to a decrease in effectiveness that goes beyond reducing the adhesive surface.

Please do not use this medicine after the expiry date stated on the pack or outer packaging.The expiry date refers to the last day of the specified month.